Prevalence of anti-HLA antibodies in COVID-19 convalescent plasma donors: an Indian experience
Background: COVID-19 convalescent plasma is one of the experimental therapies used widely in moderately sick COVID-19 patients. However, there are a few risks involved in plasma transfusion; notably, transfusion-related acute lung injury (TRALI) caused by antibodies against human leukocyte antigens...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2024-10-01
|
| coleção: | Hematology, Transfusion and Cell Therapy |
| Assuntos: | |
| Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S2531137924002207 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|